03 - Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase-II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

Notas do episódio

Discussão do artigo: "Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase-II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)" de Esther Natalie Oliva, Journal of Clinical Oncology 2023. Apresentado por: Nicole Marques Discussão por: Breno Aires, Diego Luz, Matheus Puls, Pedro Flores, Thais Fernanda, Pedro Arruda e Vinícius Molla.